Literature DB >> 26361820

A simple and inexpensive method to control oxygen concentrations within physiological and neoplastic ranges.

P G Penketh1, K Shyam2, R P Baumann2, E S Ratner3, A C Sartorelli2.   

Abstract

Traditional methods for regulating oxygen concentration ([O2]) in in vitro experiments over the range found in normal and tumor tissues require the use of expensive equipment to generate controlled gas atmospheres or the purchase of a range of gas cylinders with certified O2 percentages. Here we describe a simple and inexpensive enzymatic method for generating low, precise steady-state [O2] levels that are stable for several hours. This method is particularly applicable to the in vitro study of some classes of hypoxia-targeted antitumor prodrugs and bioreductively activated agents.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bioreductive; Hypoxia; Nitrofurazone; Oxygen; Prodrug; Tumor

Mesh:

Substances:

Year:  2015        PMID: 26361820      PMCID: PMC4631621          DOI: 10.1016/j.ab.2015.08.032

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  11 in total

1.  Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302.

Authors:  Fanying Meng; James W Evans; Deepthi Bhupathi; Monica Banica; Leslie Lan; Gustavo Lorente; Jian-Xin Duan; Xiaohong Cai; Alexandra M Mowday; Christopher P Guise; Andrej Maroz; Robert F Anderson; Adam V Patterson; Gregory C Stachelek; Peter M Glazer; Mark D Matteucci; Charles P Hart
Journal:  Mol Cancer Ther       Date:  2011-12-06       Impact factor: 6.261

2.  1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells.

Authors:  Helen A Seow; Philip G Penketh; Krishnamurthy Shyam; Sara Rockwell; Alan C Sartorelli
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-17       Impact factor: 11.205

3.  Effect of periodate oxidation on the structure and properties of glucose oxidase.

Authors:  S Nakamura; S Hayashi; K Koga
Journal:  Biochim Biophys Acta       Date:  1976-09-14

4.  Dissection of NADPH-cytochrome P450 oxidoreductase into distinct functional domains.

Authors:  G C Smith; D G Tew; C R Wolf
Journal:  Proc Natl Acad Sci U S A       Date:  1994-08-30       Impact factor: 11.205

5.  An experimental and analytical study of oxygen depletion in stirred cell suspensions.

Authors:  D W Whillans; A M Rauth
Journal:  Radiat Res       Date:  1980-10       Impact factor: 2.841

Review 6.  Targeting hypoxia in cancer therapy.

Authors:  William R Wilson; Michael P Hay
Journal:  Nat Rev Cancer       Date:  2011-06       Impact factor: 60.716

7.  Increased cell killing by metronidazole and nitrofurazone of hypoxic compared to aerobic mammalian cells.

Authors:  J K Mohindra; A M Rauth
Journal:  Cancer Res       Date:  1976-03       Impact factor: 12.701

8.  Generation of oxygen deficiency in cell culture using a two-enzyme system to evaluate agents targeting hypoxic tumor cells.

Authors:  Raymond P Baumann; Philip G Penketh; Helen A Seow; Krishnamurthy Shyam; Alan C Sartorelli
Journal:  Radiat Res       Date:  2008-11       Impact factor: 2.841

9.  Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs.

Authors:  Jian-Xin Duan; Hailong Jiao; Jacob Kaizerman; Timothy Stanton; James W Evans; Leslie Lan; Gustavo Lorente; Monica Banica; Don Jung; Jinwei Wang; Huaiyu Ma; Xiaoming Li; Zhijian Yang; Robert M Hoffman; W Steve Ammons; Charles P Hart; Mark Matteucci
Journal:  J Med Chem       Date:  2008-02-08       Impact factor: 7.446

10.  Oxygen dependence of the cytotoxicity and metabolic activation of 4-alkylamino-5-nitroquinoline bioreductive drugs.

Authors:  B G Siim; G J Atwell; W R Wilson
Journal:  Br J Cancer       Date:  1994-10       Impact factor: 7.640

View more
  1 in total

1.  Physicochemical Considerations of Tumor Selective Drug Delivery and Activity Confinement with Particular Reference to 1,2-Bis(Sulfonyl)-1- Alkylhydrazines Delivery.

Authors:  Philip Penketh; Hugh Williamson; Krishnamurthy Shyam
Journal:  Curr Drug Deliv       Date:  2020       Impact factor: 2.565

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.